# Clindamycin Phosphate Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current, To Be Discontinued - FDA package records: 26 - Latest FDA row update: 08/18/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Baxter Healthcare — Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) — FDA availability: Available — updated: 08/17/2026 - Baxter Healthcare — Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) — FDA availability: Available — updated: 08/17/2026 - Baxter Healthcare — Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) — FDA availability: Available — updated: 08/17/2026 - Baxter Healthcare — Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) — FDA availability: Unavailable — updated: 08/17/2026 - Baxter Healthcare — Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) — FDA availability: Limited Availability — updated: 08/17/2026 - Baxter Healthcare — Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) — FDA availability: Available — updated: 08/17/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02) — FDA availability: Unavailable — updated: 08/07/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26) — FDA availability: Not stated — updated: 06/01/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02) — FDA availability: Not stated — updated: 06/01/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL) (NDC 0009-4073-04) — FDA availability: Unavailable — updated: 08/07/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26) — FDA availability: Not stated — updated: 06/01/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04) — FDA availability: Not stated — updated: 06/01/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06) — FDA availability: Unavailable — updated: 08/07/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18) — FDA availability: Not stated — updated: 06/01/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06) — FDA availability: Not stated — updated: 06/01/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) — FDA availability: Unavailable — updated: 08/07/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) — FDA availability: Available — updated: 08/07/2026 - Pfizer Inc. — Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) — FDA availability: Available — updated: 08/07/2026 - Sagent Pharmaceuticals — Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) — FDA availability: Limited Availability — updated: 08/18/2026 - Sagent Pharmaceuticals — Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) — FDA availability: Unavailable — updated: 08/18/2026 - Sagent Pharmaceuticals — Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) — FDA availability: Limited Availability — updated: 08/18/2026 - Sandoz Inc. — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) — FDA availability: Available — updated: 08/18/2026 - Sandoz Inc. — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) — FDA availability: Available — updated: 08/18/2026 - Sandoz Inc. — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) — FDA availability: Available — updated: 08/18/2026 - Sandoz Inc. — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) — FDA availability: Available — updated: 08/18/2026 - Sandoz Inc. — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) — FDA availability: Available — updated: 08/18/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/clindamycin-phosphate-injection) - [JSON record](https://citefacts.com/shortages/clindamycin-phosphate-injection.json)